PFSA

NASDAQ

Profusa

$5.46
-2.11 (-27.87%)
2026-08-21 00:00
Healthcare Medical Devices
-- --

Short Interest (1 Year)

% of Volume Sold Short
Market Cap
$551K
P/E Ratio
N/A
52W Low 52W High
$0.05 $28.32
Volume
617K

About Profusa

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berk...

Website profusa.com

Financial Highlights

Annual Quarterly
Year Revenue Op Margin Net Income Free Cash Flow
2025 N/A N/A% -$35.8M -$16.2M
2024 N/A N/A% -$9.2M -$2.1M
2023 N/A N/A% -$10.3M -$4.4M
2022 N/A N/A% -$20.2M -$7.7M
2021 N/A N/A% -$10.3M -$10.7M